Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer

Overview of attention for article published in Frontiers in Pharmacology, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 1 news story.

Apalutamide plus androgen deprivation therapy (ADT) as neoadjuvant therapy prior to radical prostatectomy improves the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.